+
Sun Pharma to Declare Q4 Results on May 22, 2025
ECONOMY & POLICY

Sun Pharma to Declare Q4 Results on May 22, 2025

Sun Pharmaceutical Industries will announce results for the fourth quarter ended March 31, 2025, on May 22, 2025. The Company will conduct an hour-long call at 06.30 pm IST on May 22, 2025, where senior management will discuss the Company’s performance and answer questions from participants. To participate in this conference call, please pre-register yourself on the below link and dial the numbers provided below, five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.

Sun Pharma is the world’s leading specialty generics company with a presence in Specialty, Generics and Consumer Healthcare products. It is the largest pharmaceutical company in India and is a leading generic company in the US as well as Global Emerging Markets. Sun’s high growth Global Specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales. The company’s vertically integrated operations deliver high-quality medicines, trusted by physicians and consumers in over 100 countries. Its manufacturing facilities are spread across six continents. Sun Pharma is proud of its multi-cultural workforce drawn from over 50 nations.

Sun Pharmaceutical Industries will announce results for the fourth quarter ended March 31, 2025, on May 22, 2025. The Company will conduct an hour-long call at 06.30 pm IST on May 22, 2025, where senior management will discuss the Company’s performance and answer questions from participants. To participate in this conference call, please pre-register yourself on the below link and dial the numbers provided below, five to ten minutes ahead of the scheduled start time. The operator will provide instructions on asking questions before the call. You can also hear the call via an audio webcast, details of which will be announced later on the Company website, www.sunpharma.com. A transcript of this conference call will also be available on the website.Sun Pharma is the world’s leading specialty generics company with a presence in Specialty, Generics and Consumer Healthcare products. It is the largest pharmaceutical company in India and is a leading generic company in the US as well as Global Emerging Markets. Sun’s high growth Global Specialty portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for over 18% of company sales. The company’s vertically integrated operations deliver high-quality medicines, trusted by physicians and consumers in over 100 countries. Its manufacturing facilities are spread across six continents. Sun Pharma is proud of its multi-cultural workforce drawn from over 50 nations.

Next Story
Infrastructure Transport

NHAI to Upgrade Thanjavur-Pudukottai Highway in Tamil Nadu

The National Highways Authority of India (NHAI) is preparing to upgrade the national highway stretch linking Thanjavur and Pudukottai via Gandarvakottai in Tamil Nadu.The project, valued at Rs 450 million, has been awarded and construction activity is expected to commence shortly.This initiative will be carried out under a performance-based maintenance contract—the first of its kind in the state—where the contractor will not only execute the work but also maintain the 55-kilometre stretch for five years.According to a senior NHAI official quoted in The Hindu, preliminary works have already..

Next Story
Infrastructure Urban

Major Investments Boost Andhra Pradesh’s Industrial Growth

Industries, Commerce, and Food Processing Minister T.G. Bharat stated that substantial investments are flowing into Andhra Pradesh under the leadership of Chief Minister N. Chandrababu Naidu. During his visit to the Achyutapuram Special Economic Zone (APSEZ) in Anakapalli district, the minister reviewed the progress of ongoing projects alongside APIIC zonal officials and engineers from the head office.He discussed developments in the bulk drug cluster at Nakkapalli, updates on various NS projects, and the ongoing Green Hydrogen initiative within the SEZ. The minister also assessed the developm..

Next Story
Real Estate

Vishnusurya Secures Rs 1 Billion Contract for Chennai Desalination Plant

Vishnusurya Projects and Infra Ltd, a construction and infrastructure company specialising in engineering, procurement, and construction (EPC), has secured a Rs 1.03 billion contract from JWIL Infra Ltd, a water management firm offering comprehensive solutions.The contract involves laying, testing, and commissioning pipelines, along with necessary civil works, for a proposed 400 million litre per day desalination plant at Perur near Chennai, Vishnusurya Projects stated in a press release on Saturday. The project timeline is 17 months.The Chennai Metropolitan Water Supply and Sewerage Board awa..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?